Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluticasone + omeprazole
- Development stage
- Phase 4
- Lead developer
- Claire Daniels
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination therapy consists of the proton pump inhibitor (PPI) omeprazole and the topical corticosteroid fluticasone. It is being investigated for the treatment of eosinophilic esophagitis (EoE). While omeprazole is traditionally used for acid suppression, in the context of EoE, it has been shown to inhibit STAT6 binding to the eotaxin-3 promoter, thereby reducing the recruitment of eosinophils to the esophageal mucosa through an anti-inflammatory mechanism independent of its effect on gastric acid. Fluticasone acts as a local anti-inflammatory agent to further reduce eosinophilic infiltration. The combination is being evaluated in a Phase 4 clinical trial (NCT03781596) sponsored by Claire Daniels at Walter Reed National Military Medical Center to determine if dual therapy is superior to fluticasone monotherapy in children and adults.
- Other names
- omeprazole + fluticasonefluticasone plus omeprazole
02
Targets
GR (Glucocorticoid receptor)ATP4A (Potassium–transporting ATPase alpha chain 1)STAT6 (Signal Transducer and Activator of Transcription 6)
Beyond the preview
Go deeper on fluticasone + omeprazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluticasone + omeprazole.